The Asia Pacific Vascular Patches Market should witness market growth of 7.9% CAGR during the forecast period (2022-2028).
The development of vascular surgery techniques and the treatment of vascular diseases will be influenced by impending technological developments. Superior medical interventions to halt or even combat atherosclerosis are on the horizon. Statin medications are just becoming widely available, yet their use has already decreased the number of strokes, heart attacks, and fatalities. Statin medication applications will be successful, improve treatments, and aid in improving treatment outcomes.
There are increasing hints of computer-aided 3-dimensional tool navigational equipment. The likelihood that radiation-based therapies will no longer be used is increasing, which lowers the hazards that patients and medical professionals may face during such procedures. Robotic developments would also reduce radiation exposure and make device placement easier.
The prevention of perioperative and long-term strokes has benefited from randomized planned preliminary studies and meta-examinations, which have also decreased the incidence of recurrent restenosis, or the condition in which a portion of a blocked vessel narrows again after reconstruction and subsequently becomes blocked, necessitating additional stenting or bypass surgery.
The main driver influencing the market's growth in China is the country's increasingly aging population, which is suffering from cardiovascular disease. The market development in Japan is driven by the growing use of biological patches for treating various vascular conditions like carotid artery stenosis and peripheral artery disease.
The China market dominated the Asia Pacific Vascular Patches Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $41, 515.5 Thousands by 2028. The Japan market is estimated to grow a CAGR of 7.3% during (2022-2028). Additionally, The India market would experience a CAGR of 8.6% during (2022-2028).
Based on Material, the market is segmented into Biologic and Synthetic. Based on End-user, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on Application, the market is segmented into Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, Baxter International, Inc., Lemaitre Vascular, Inc., Becton, Dickinson and Company, Terumo Corporation, Aziyo Biologics, Inc., Getinge AB, B. Braun Melsungen AG, Artivion, Inc. (CryoLife, Inc.), and W. L. Gore & Associates, Inc.
The development of vascular surgery techniques and the treatment of vascular diseases will be influenced by impending technological developments. Superior medical interventions to halt or even combat atherosclerosis are on the horizon. Statin medications are just becoming widely available, yet their use has already decreased the number of strokes, heart attacks, and fatalities. Statin medication applications will be successful, improve treatments, and aid in improving treatment outcomes.
There are increasing hints of computer-aided 3-dimensional tool navigational equipment. The likelihood that radiation-based therapies will no longer be used is increasing, which lowers the hazards that patients and medical professionals may face during such procedures. Robotic developments would also reduce radiation exposure and make device placement easier.
The prevention of perioperative and long-term strokes has benefited from randomized planned preliminary studies and meta-examinations, which have also decreased the incidence of recurrent restenosis, or the condition in which a portion of a blocked vessel narrows again after reconstruction and subsequently becomes blocked, necessitating additional stenting or bypass surgery.
The main driver influencing the market's growth in China is the country's increasingly aging population, which is suffering from cardiovascular disease. The market development in Japan is driven by the growing use of biological patches for treating various vascular conditions like carotid artery stenosis and peripheral artery disease.
The China market dominated the Asia Pacific Vascular Patches Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $41, 515.5 Thousands by 2028. The Japan market is estimated to grow a CAGR of 7.3% during (2022-2028). Additionally, The India market would experience a CAGR of 8.6% during (2022-2028).
Based on Material, the market is segmented into Biologic and Synthetic. Based on End-user, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on Application, the market is segmented into Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, Baxter International, Inc., Lemaitre Vascular, Inc., Becton, Dickinson and Company, Terumo Corporation, Aziyo Biologics, Inc., Getinge AB, B. Braun Melsungen AG, Artivion, Inc. (CryoLife, Inc.), and W. L. Gore & Associates, Inc.
Scope of the Study
By Material
- Biologic
- Synthetic
By End-user
- Hospitals
- Ambulatory Surgical Centers
By Application
- Carotid Endarterectomy
- Open Repair of Abdominal Aortic Aneurysm
- Vascular Bypass Surgery
- Congenital Heart Disease
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Edwards Lifesciences Corporation
- Baxter International, Inc.
- Lemaitre Vascular, Inc.
- Becton, Dickinson and Company
- Terumo Corporation
- Aziyo Biologics, Inc.
- Getinge AB
- B.Braun Melsungen AG
- Artivion, Inc. (CryoLife, Inc.)
- W.L. Gore & Associates, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Vascular Patches Market, by Material
1.4.2 Asia Pacific Vascular Patches Market, by End User
1.4.3 Asia Pacific Vascular Patches Market, by Application
1.4.4 Asia Pacific Vascular Patches Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Vascular Patches Market
Chapter 4. Asia Pacific Vascular Patches Market by Material
4.1 Asia Pacific Biologic Market by Country
4.2 Asia Pacific Synthetic Market by Country
Chapter 5. Asia Pacific Vascular Patches Market by End User
5.1 Asia Pacific Hospitals Market by Country
5.2 Asia Pacific Ambulatory Surgical Centers Market by Country
Chapter 6. Asia Pacific Vascular Patches Market by Application
6.1 Asia Pacific Carotid Endarterectomy Market by Country
6.2 Asia Pacific Open Repair of Abdominal Aortic Aneurysm Market by Country
6.3 Asia Pacific Vascular Bypass Surgery Market by Country
6.4 Asia Pacific Congenital Heart Disease Market by Country
6.5 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Vascular Patches Market by Country
7.1 China Vascular Patches Market
7.1.1 China Vascular Patches Market by Material
7.1.2 China Vascular Patches Market by End User
7.1.3 China Vascular Patches Market by Application
7.2 Japan Vascular Patches Market
7.2.1 Japan Vascular Patches Market by Material
7.2.2 Japan Vascular Patches Market by End User
7.2.3 Japan Vascular Patches Market by Application
7.3 India Vascular Patches Market
7.3.1 India Vascular Patches Market by Material
7.3.2 India Vascular Patches Market by End User
7.3.3 India Vascular Patches Market by Application
7.4 South Korea Vascular Patches Market
7.4.1 South Korea Vascular Patches Market by Material
7.4.2 South Korea Vascular Patches Market by End User
7.4.3 South Korea Vascular Patches Market by Application
7.5 Singapore Vascular Patches Market
7.5.1 Singapore Vascular Patches Market by Material
7.5.2 Singapore Vascular Patches Market by End User
7.5.3 Singapore Vascular Patches Market by Application
7.6 Malaysia Vascular Patches Market
7.6.1 Malaysia Vascular Patches Market by Material
7.6.2 Malaysia Vascular Patches Market by End User
7.6.3 Malaysia Vascular Patches Market by Application
7.7 Rest of Asia Pacific Vascular Patches Market
7.7.1 Rest of Asia Pacific Vascular Patches Market by Material
7.7.2 Rest of Asia Pacific Vascular Patches Market by End User
7.7.3 Rest of Asia Pacific Vascular Patches Market by Application
Chapter 8. Company Profiles
8.1 Edwards Lifesciences Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.2 Baxter International, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Lemaitre Vascular, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Terumo Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Regional Analysis
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Aziyo Biologics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.7 Getinge AB
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 B. Braun Melsungen AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Artivion, Inc. (CryoLife, Inc.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. W. L. Gore & Associates, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
Companies Mentioned
- Edwards Lifesciences Corporation
- Baxter International, Inc.
- Lemaitre Vascular, Inc.
- Becton, Dickinson and Company
- Terumo Corporation
- Aziyo Biologics, Inc.
- Getinge AB
- B. Braun Melsungen AG
- Artivion, Inc. (CryoLife, Inc.)
- W. L. Gore & Associates, Inc.
Methodology
LOADING...
